Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

The policy requires inclusion and subpopulation data in the progress report for each NIH-defined Phase III clinical trial grant or contract. Does that mean that analyses need to be done every year?

0
Posted

The policy requires inclusion and subpopulation data in the progress report for each NIH-defined Phase III clinical trial grant or contract. Does that mean that analyses need to be done every year?

0

NO. The progress report needs to report cumulative accrual data annually and explain progress in conducting analyses for sex/gender and/or racial/ethnic differences. If analyses of sex/gender and/or racial/ethnic differences are not available at the time of the progress report, then a justification and/or interim data analyses must be reported. Analyses should be conducted when permitted by the study design and as described in the analysis plan. For contracts, the schedule of deliverables will dictate when reports and analyses are required.

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.

Experts123